These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18216371)

  • 1. Spill and leakage using a drug preparation system based on double-filter technology.
    Nygren O; Olofsson E; Johansson L
    Ann Occup Hyg; 2008 Mar; 52(2):95-8. PubMed ID: 18216371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A test method for assessment of spill and leakage from drug preparation systems.
    Nygren O; Gustavsson B; Eriksson R
    Ann Occup Hyg; 2005 Nov; 49(8):711-8. PubMed ID: 16126763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislation.
    Baldo P; Bertola A; Basaglia G; Moneghini M; Sorio R; Zibardi E; Lazzarini R; De Paoli P
    J Eval Clin Pract; 2007 Apr; 13(2):265-71. PubMed ID: 17378874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Availability evaluation of closed systems by using practical training kits for preparation of antitumor drugs].
    Sato J; Odagiri N; Terui K; Iwasaki Y; Hosoya E; Hayakari M
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1753-7. PubMed ID: 20841940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aseptic simulation test for cytotoxic drug production in isolators.
    Savry A; Correard F; Bennis Y; Roubaud S; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Mar; 71(6):476-81. PubMed ID: 24589539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improvement of quality of practices for the preparation of cytotoxic drugs: results of a "before-after" study].
    Gilles L; Favier B; Catillon F; Dussart C; Peyron F; Simoens X; Latour JF; Farsi F; Biron P
    Bull Cancer; 2009 Sep; 96(9):839-49. PubMed ID: 19696008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a closed drug preparation method for oral anticancer drugs.
    Wakui N; Ookubo T; Iwasaki Y; Ito R; Saito K; Nakazawa H
    J Oncol Pharm Pract; 2013 Dec; 19(4):315-20. PubMed ID: 23292970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous training program for technicians handling antineoplastic drugs and occupational exposure risk].
    Dussart C; Favier B; Gilles L; Camal I; Almeras D; Latour JF; Grelaud G
    Bull Cancer; 2008 Sep; 95(9):821-2. PubMed ID: 18829414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical considerations in the preparation and dispensing of chemotherapy.
    Peters BG
    Top Hosp Pharm Manage; 1995 Jan; 14(4):78-88. PubMed ID: 10140430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Centralized preparations of cytostatic agents: a method for quality control].
    Wernli M; Bögli F; Mühlebach S; Conen D
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1962-5. PubMed ID: 7973528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers].
    Favier B; Gilles L; Desage M; Latour JF
    Bull Cancer; 2003 Oct; 90(10):905-9. PubMed ID: 14706919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leakage from closed-system transfer devices as detected by a radioactive tracer.
    De Ausen L; DeFreitas EF; Littleton L; Lustik M
    Am J Health Syst Pharm; 2013 Apr; 70(7):619-23. PubMed ID: 23515515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISOPP standards of practice. Safe handling of cytotoxics.
    International Society of Oncology Pharmacy Practicioners Standards Committee
    J Oncol Pharm Pract; 2007; 13 Suppl():1-81. PubMed ID: 17933809
    [No Abstract]   [Full Text] [Related]  

  • 17. Safe Cytotoxic Drug Preparation Using Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal).
    Garrigue P; Montana M; Ventre C; Savry A; Gauthier-Villano L; Pisano P; Pourroy B
    Int J Pharm Compd; 2016; 20(2):148-54. PubMed ID: 27323425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving safety through behavior and gas exposure tracking.
    Wagner DD
    Occup Health Saf; 2008 May; 77(5):43-4, 46-7. PubMed ID: 18536353
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs.
    Forshay CM; Streeter SO; Salch SA; Eckel SF
    J Oncol Pharm Pract; 2019 Jul; 25(5):1160-1166. PubMed ID: 30041583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting acquainted with confined spaces.
    Ball W
    Occup Health Saf; 2008 May; 77(5):48, 50-2. PubMed ID: 18536354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.